Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating activities
Net loss	$ (6,865,590)	$ (10,886,809)
Adjustments to reconcile net loss to net cash used in operating activities:
Forgiveness of paycheck protection loan and accrued interest	(105,130)
Stock-based compensation expense	1,424,754	1,151,691
Change in operating assets and liabilities:
Accounts receivable, net	(198,855)
Prepaid expenses, inventory and other assets	1,055,913	261,552
Accounts payable and other current liabilities	(835,632)	(370,639)
Accrued compensation	(205,442)	(127,740)
Accrued interest expense	374,236	53,442
Milestone payable	(5,000,000)	5,000,000
Net cash used in operating activities	(10,355,746)	(4,918,503)
Financing activities
Proceeds from issuance of common stock, net	13,070,154
Proceeds from issuance of common stock from ATM, net	313,107	3,309,116
Proceeds from issuance of common stock from exercise of stock options	45,454	2,627
Proceeds from issuance of common stock from employee stock purchase plan		119,415
Proceeds from paycheck protection program		104,168
Proceeds from Eversana line of credit		2,000,000
Net cash provided by financing activities	13,428,715	5,535,326
Net increase in cash and cash equivalents	3,072,969	616,823
Cash and cash equivalents at beginning of period	8,068,939	5,663,833
Cash and cash equivalents at end of period	11,141,908	$ 6,280,656
Non-cash financing activities
Forgiveness of paycheck protection loan and accrued interest	$ 105,130